A detailed history of Atlas Capital Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 2,902 shares of PFE stock, worth $76,496. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,902
Previous 1,102 163.34%
Holding current value
$76,496
Previous $30.8 Million 172.37%
% of portfolio
0.01%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$27.7 - $31.39 $49,860 - $56,502
1,800 Added 163.34%
2,902 $84 Million
Q2 2024

Jul 29, 2024

SELL
$25.26 - $29.6 $15,156 - $17,760
-600 Reduced 35.25%
1,102 $30.8 Million
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $15,534 - $17,838
600 Added 54.45%
1,702 $47.2 Million
Q4 2023

Feb 15, 2024

SELL
$26.13 - $33.94 $80,375 - $104,399
-3,076 Reduced 73.62%
1,102 $31.7 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $25,768 - $30,120
-803 Reduced 16.12%
4,178 $139 Million
Q2 2023

Aug 15, 2023

SELL
$36.12 - $41.79 $49,990 - $57,837
-1,384 Reduced 21.74%
4,981 $183 Million
Q1 2023

May 16, 2023

SELL
$39.39 - $51.28 $886,550 - $1.15 Million
-22,507 Reduced 77.95%
6,365 $260 Million
Q4 2022

Feb 15, 2023

SELL
$41.75 - $54.5 $57,155 - $74,610
-1,369 Reduced 4.53%
28,872 $1.48 Billion
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $6,782 - $8,280
-155 Reduced 0.51%
30,241 $1.32 Billion
Q2 2022

Aug 16, 2022

SELL
$46.53 - $55.17 $109,810 - $130,201
-2,360 Reduced 7.2%
30,396 $1.59 Billion
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $17,796 - $22,052
389 Added 1.2%
32,756 $1.7 Billion
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $178,543 - $264,661
4,321 Added 15.41%
32,367 $1.91 Billion
Q3 2021

Oct 28, 2021

BUY
$39.25 - $50.42 $778,249 - $999,727
19,828 Added 241.28%
28,046 $1.21 Million
Q2 2021

Jul 30, 2021

BUY
$35.91 - $40.68 $897 - $1,017
25 Added 0.31%
8,218 $321,000
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $60,148 - $67,834
-1,796 Reduced 17.98%
8,193 $296,000
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $132,574 - $168,580
-3,961 Reduced 28.39%
9,989 $367,000
Q3 2020

Oct 23, 2020

SELL
$31.75 - $37.25 $36,830 - $43,210
-1,160 Reduced 7.68%
13,950 $485,000
Q2 2020

Jul 28, 2020

BUY
$30.12 - $36.54 $416,348 - $505,092
13,823 Added 1074.05%
15,110 $468,000
Q1 2020

May 04, 2020

BUY
$27.03 - $38.62 $6,081 - $8,689
225 Added 21.19%
1,287 $39,000
Q3 2019

Nov 01, 2019

SELL
$32.49 - $42.13 $350,859 - $454,961
-10,799 Reduced 91.05%
1,062 $36,000
Q2 2019

Jul 25, 2019

SELL
$36.98 - $41.52 $667,858 - $749,851
-18,060 Reduced 60.36%
11,861 $0
Q1 2019

Apr 29, 2019

SELL
$37.5 - $41.2 $118,500 - $130,192
-3,160 Reduced 9.55%
29,921 $0
Q4 2018

Jan 29, 2019

BUY
$38.47 - $43.86 $1.23 Million - $1.4 Million
32,033 Added 3056.58%
33,081 $1.37 Million
Q2 2018

Jul 30, 2018

SELL
$32.98 - $35.16 $373,861 - $398,573
-11,336 Reduced 91.54%
1,048 $0
Q1 2018

Apr 18, 2018

BUY
$31.91 - $37.02 $395,173 - $458,455
12,384 New
12,384 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.